About CYTOASTRA LLC
CytoAstra is a company focused on the early diagnosis of life-threatening diseases such as cancers, infections, and cardiovascular disorders using In Vivo Photoacoustic Flow Cytometry (PAFC). The company's platform enables noninvasive, label-free, and highly sensitive detection of rare disease biomarkers through intact skin.
In Vivo Photoacoustic Flow Cytometry (PAFC) for early disease detectionNoninvasive diagnostic testing without needles or blood drawsDetection of rare disease biomarkers in peripheral blood vesselsLabel-free detection of intrinsic biomarkers such as melanin and hemozoinRapid test results with high sensitivity (1000x improved threshold)Therapeutic device development using photoacoustic and photothermal technologies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CYTOASTRA LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.